Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment

Natalia N. Porfiryeva, Anjali Pandya, Lalitkumar K. Vora, Fabiana Volpe-Zanutto, Akmal Sabri, Priscilla Kwarteng, Jessica Mistilis, Robert K.M. Choy, Ryan F. Donnelly

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

HIV remains a global health challenge, affecting 39 million people worldwide, with the highest prevalence in Africa. Infants under one year old are particularly at risk, underscoring the need for effective and well-tolerated antiretroviral treatments, as well as preventive measures such as pre-exposure prophylaxis (PrEP), which plays a crucial role in HIV prevention strategies.
Original languageEnglish
Title of host publication5th European Conference on Pharmaceutics: Proceedings
Publication statusPublished (in print/issue) - 25 Mar 2025

Fingerprint

Dive into the research topics of 'Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment'. Together they form a unique fingerprint.

Cite this